AMP Pharmacogenomics (PGx) Genotyping Recommendations |
Introduction & Directions
| 8% |
The Association for Molecular Pathology (AMP) Clinical Practice Committee’s Pharmacogenomics (PGx) Working Group with representation from the American College of Medical Genetics and Genomics (ACMG), Clinical Pharmacogenetics Implementation Consortium (CPIC), College of American Pathologists (CAP), Dutch Pharmacogenetics Working Group (DPWG) of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy (ESPT), Pharmacogenomics Knowledgebase (PharmGKB), and Pharmacogene Variation Consortium (PharmVar) has developed a series of documents that recommend a minimum set of variants to include in clinical PGx assays to facilitate standardization across laboratories and ensure that clinically relevant variant alleles are included in clinical PGx assays.
PURPOSE: This survey is designed to understand the impact and evaluate the implementation of the AMP PGx Working Group's series of recommendations on clinical PGx testing.
TARGET AUDIENCE: This survey is designed to capture individual responses from molecular laboratory professionals currently performing, planning to perform, or who have decided not to perform clinical testing for PGx in their laboratories. One individual per laboratory should respond, ideally the laboratory director decision maker.
NOTE - This survey is NOT restricted to AMP members, so please feel free to share the survey link widely with your colleagues who may also be working in this space. If your organization or company would like to provide feedback on the survey please contact the AMP Clinical Affairs team at AMPClinicalPractice@amp.org.
TARGET AUDIENCE: This survey is designed to capture individual responses from molecular laboratory professionals currently performing, planning to perform, or who have decided not to perform clinical testing for PGx in their laboratories. One individual per laboratory should respond, ideally the laboratory director decision maker.
NOTE - This survey is NOT restricted to AMP members, so please feel free to share the survey link widely with your colleagues who may also be working in this space. If your organization or company would like to provide feedback on the survey please contact the AMP Clinical Affairs team at AMPClinicalPractice@amp.org.
This survey is anonymous; all data collected will be used in aggregate form.
The collector settings will only permit one response from each device. Please be sure to click the Complete Survey and Exit button at the end of the survey to register your responses as complete.